BENSALEM, Pa.–(BUSINESS WIRE)–$IRTC #CLASSACTION–Law Offices of Howard G. Smith announces an investigation on behalf of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) investors concerning the Company’s possible violations of federal securities laws.
iRhythm Technologies provides wearable biosensor devices to detect and monitor heart arrhythmias.
On December 2, 2020, iRhythm issued a press release stating that new Centers for Medicare and Medicaid Services (CMS) physician fee guidelines would change how payments for its Zio XT remote cardiac monitoring services would be calculated.
On this news, the Company’s stock price dropped approximately 20%.
On January 29, 2021, a research analyst from Baird indicated that the recent publication by Novitas Solutions, a Medicare Administrative Contractor, of reimbursement rates for CPT codes are “way lower than” those published in the Medicare Physician Fee Schedule.
On this news, the Company’s stock price fell $82.58, or 32.90%, to close at $168.42 per share on January 29, 2021, thereby injuring investors further.
If you purchased iRhythm securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Powered by WPeMatico